Related Experiment Videos
Polycystic ovary syndrome and ovulation induction
1Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. William_Phipps@URMC.Rochester.edu
Obstetrics and Gynecology Clinics of North America
|April 11, 2001
Summary
Before ovulation induction for Polycystic Ovary Syndrome (PCOS), individualized patient evaluation is key. Weight loss, clomiphene citrate, metformin, gonadotropins, or laparoscopic ovarian drilling are treatment options.
Area of Science:
- Reproductive Endocrinology
- Infertility Management
Background:
- Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder associated with ovulatory dysfunction.
- Effective management of PCOS-related infertility requires a tailored approach.
Purpose of the Study:
- To outline an evidence-based strategy for ovulation induction in patients with PCOS.
- To guide clinicians in selecting appropriate treatments based on individual patient factors.
Main Methods:
- Review of current literature and clinical guidelines for PCOS management.
- Emphasis on pre-treatment evaluation, including assessment of obesity and partner fertility.
- Discussion of pharmacologic and surgical treatment options.
Main Results:
- Weight loss is recommended for obese PCOS patients prior to pharmacologic therapy.
- Clomiphene citrate, often with a glucocorticoid, is the first-line pharmacologic agent.
- Metformin, alone or with clomiphene citrate, may be beneficial.
- Injectable gonadotropins or laparoscopic ovarian drilling are options for clomiphene-resistant cases.
Conclusions:
- Individualized patient assessment is crucial for optimizing ovulation induction outcomes in PCOS.
- A stepwise treatment approach, starting with lifestyle modifications and progressing to pharmacologic or surgical interventions, is recommended.